These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11238235)

  • 1. Development of a novel screen for protease inhibitors.
    Gillim L; Gusella GL; Vargas J; Marras D; Klotman ME; Cara A
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):437-40. PubMed ID: 11238235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
    Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
    J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.
    Garcia-Perez J; Sanchez-Palomino S; Perez-Olmeda M; Fernandez B; Alcami J
    J Med Virol; 2007 Feb; 79(2):127-37. PubMed ID: 17177310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance within the protease inhibitor class.
    Race E
    Antivir Ther; 2001; 6 Suppl 2():29-36. PubMed ID: 11678476
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385.
    Yates PJ; Hazen R; St Clair M; Boone L; Tisdale M; Elston RC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1092-5. PubMed ID: 16495277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hierarchical model of HIV-1 protease drug resistance.
    Goodsell DS
    Appl Bioinformatics; 2002; 1(1):3-12. PubMed ID: 15130852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli.
    Cheng YS; Lo KH; Hsu HH; Shao YM; Yang WB; Lin CH; Wong CH
    J Virol Methods; 2006 Oct; 137(1):82-7. PubMed ID: 16849028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance.
    Stoffler D; Sanner MF; Morris GM; Olson AJ; Goodsell DS
    Proteins; 2002 Jul; 48(1):63-74. PubMed ID: 12012338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection study.
    Dandache S; Coburn CA; Oliveira M; Allison TJ; Holloway MK; Wu JJ; Stranix BR; Panchal C; Wainberg MA; Vacca JP
    J Med Virol; 2008 Dec; 80(12):2053-63. PubMed ID: 19040279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive inhibitors of the HIV-1 protease.
    Ohtaka H; Freire E
    Prog Biophys Mol Biol; 2005 Jun; 88(2):193-208. PubMed ID: 15572155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibition in African subtypes of HIV-1.
    Velázquez-Campoy A; Vega S; Fleming E; Bacha U; Sayed Y; Dirr HW; Freire E
    AIDS Rev; 2003; 5(3):165-71. PubMed ID: 14598565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constraints on the sequence diversity of the protease of human immunodeficiency virus type 1: a guide for drug design.
    Kaplan AH
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):849-53. PubMed ID: 8798968
    [No Abstract]   [Full Text] [Related]  

  • 13. A rapid screening method for biological activity of human immunodeficiency virus proteinase inhibitors by using a recombinant DNA-derived bacterial system.
    Sedlácek J; Fábry M; Horejsí M; Brynda J; Luftig RB; Majer P
    Anal Biochem; 1993 Dec; 215(2):306-9. PubMed ID: 8122796
    [No Abstract]   [Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo.
    Zachary KC; Hanna GJ; D'Aquila RT
    Clin Infect Dis; 2001 Dec; 33(12):2075-7. PubMed ID: 11700580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates.
    Gonzalez LM; Santos AF; Abecasis AB; Van Laethem K; Soares EA; Deforche K; Tanuri A; Camacho R; Vandamme AM; Soares MA
    J Antimicrob Chemother; 2008 Jun; 61(6):1201-4. PubMed ID: 18356151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication.
    Margerison ES; Maguire M; Pillay D; Cane P; Elston RC
    J Antimicrob Chemother; 2008 Apr; 61(4):786-91. PubMed ID: 18252693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients.
    Torti C; Quiros-Roldan E; Monno L; Patroni A; Saracino A; Angarano G; Tinelli C; Lo Caputo S; Tirelli V; Mazzotta F; Carosi G; ;
    J Med Virol; 2004 Sep; 74(1):29-33. PubMed ID: 15258965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface.
    Bannwarth L; Reboud-Ravaux M
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):551-4. PubMed ID: 17511649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor.
    Sévigny G; Stranix B; Tian B; Dubois A; Sauvé G; Petropoulos C; Lie Y; Hellmann N; Conway B; Yelle J
    Antiviral Res; 2006 Jun; 70(2):17-20. PubMed ID: 16473417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.